Role of Cytokines and Cytokine Therapy in Wound Healing and Fibrotic Diseases
Authors: Gharee-Kermani, M.; Pham, S.H.
Source: Current Drug Metabolism, Volume 7, Number 11, 1 July 2001 , pp. 1083-1103(21)
Publisher: Bentham Science Publishers
Abstract:
Cytokines are critical to a myriad of fundamental homeostatic and pathophysiological processes such as fever, wound healing, inflammation, tissue repair and fibrosis. They play important roles in regulating cell function such as proliferation, migration, and matrix synthesis. It is the balance or the net effect of the complex interplay between these mediators, which appears to play a major role in regulating the initiation, progression and resolution of wounds. Wound healing involves a complex process including induction of acute inflammation by the initial injury, followed by parenchymal and mesenchymal cell proliferation, migration, and activation with production and deposition of extracellular matrix. Failure to resolve or abnormal wound healing results in fibrosis. The latter process involves similar cellular interactions via complex cytokine networks, which result in extensive remodeling with heightened extracellular matrix production and their abnormal deposition in the tissue. Various cytokines, both promoting and inhibiting fibrogenesis, have been implicated in the pathogenesis of fibrosis and wound healing. Recent progress in understanding the mechanisms underlying the pathogenesis of fibrosis leads us to expect that inhibitors of pro-fibrogenic cytokines and growth factors may be useful as novel therapeutic agents in controlling undesirable fibrosis. In this review, the role of cytokines in wound healing and fibrosis will be summarized and highlighted with more detailed discussion reserved for the possible points of therapeutic attack in pulmonary fibrosis. In this review, the major cytokines that are in current clinical use will be also discussed. In addition, advances in the application of novel cytokines and anti-cytokines for accelerating wound healing and attenuating fibrosis both at the experimental and the clinical trial levels will be discussed.Keywords: Cytokines; Cytokine Therapy; Wound Healing; Fibrotic Diseases; transforming growth factor b (TGFb); platelet-derived growth; WOUND HEALING; Growth Factors; TGFb; PDGF
Document Type: Review article
DOI: http://dx.doi.org/10.2174/1381612013397573
Publication date: 2001-07-01
- Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.
Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.
- In this: publication
- By this: publisher
- In this Subject: Pharmacology
- By this author: Gharee-Kermani, M. ; Pham, S.H.

Shopping cart
Receive new issue alert
Get Permissions